3D chart showing incredible symmetry just below VMA. Daily holding well above 60VMA Another daily close above current level would confirm a breakout with possible targets at 11 and 17. Bear case: for the volume seen last couple of days, price should have moved up, so makes me wary of fade below 8. Disclosure: I am long via commons with 8 as the stop...
NVAX could be forming a large Weekly Inverse Head & Shoulder. If this pattern is to break out, it likely means we have new Covid strains and potential lockdowns.
BNTX a Germany company in the biotechnology and vaccine sectors out of Europe and Germany is looking good on the 2H chart here with a volume profile and an intermediate term VWAP overlaid. Price bounced off the bottom of the high volume area of the volume profile and looks to be ready for a reversion to the mean and even a sling-short move. The target here is...
MRNA is a medical technology company. It is in the vaccine sector and competes ( well) with NVAX and PFE among others. Earnings are upcoming on 8/3 in about a week. On the 30 minute chart it appears to be in a descending wedge pattern which is typically a bottoming with a breakout over and beyond the descending trendline. The relative trend indicator shows...
VBIV popped 50 % to begin July and then promptly lost 75% and has been low volume and sideways since. I have not been able to discern any catalyst for that action. Earnings show an ongoing cash burn. In the past couple of days, the Price Volume Trend indicator has detected a small increase in the price volume product. The Relative Trend Index (RTI)...
NVAX popped today for a price jump of more than 20%. Canada agreed to pay out on a contract for COVID vaccines it now does not want in the amount of $350M. This is hardly enough to the fundamentals of the company overall. So the question arises, have traders and / or investors overreacted to a one time bonus which is essentially revenue without overhead...
NVAX has had significant down trending over a wide range of time. On the 4H chart it seems to be pivoting from a swing bottom 3-4 days ago. This is accompanied by a cross of the MACD lines under the histogram on that indicator and a flip of volatility on the relative volatility indicator. NVAX has been subject to significant short selling. Price is presently...
VAXX is a speculative penny biotechnology NASDAQ stock with high volatility. On the 2H chart, it is currently trending up from a swing low on April 25 with earnings to be reported Monday 5/8. May's relative volume compared with that of April is about 2-3X higher. To confirm the bullish bias, VAXX is currently trading above its intermediate-term POC line on...
NVAX is fundamentally weak with a shallow pipeline and no products currenly marketed to fund earnings and so research. On the 15 minute chart , NVAX is seen near to its demand zone as shown by the Luxalgo indicator. In the meanwhile, the RSI indicator shows considerable recent strength which is decreased today. So the question is whether NVAX can dead...
Not financial advice. The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
NVAX as seen on the weekly chart has been in price distress for a long time. It has only one product on the market due to various issues with the FDA process. It has a variety of products in development as linked below. The question is whether it will run out of cash before a sustained revenue stream develops. FDA approvals for the pipeline products could take...
Hi guys, NVAX showed up on my feed today as down 25% so I decided to take a look. What I see is a text book Bearish Shark attack on the stock. Looking at the embedded image in this chart you can compare the events as they occurred. The stock price has also gone back to beginning of the rally. Please do your DD this is not a financial advice.
Nice long setup in $NVAX here, you can expect a decent advance if it holds over $10.75. Best of luck! Cheers, Ivan Labrie.
If it can complete a structure I am looking for then it can potentially run to 30s best case, but more likely 19-22. Worst case it has downside risk to 4 if this structure falls apart. Rejection from re-entering blue channel would imply the latter. Good news would be necessary for the best case. The more likely case is just a technical gap fill - would happen...
Novavax - 30d expiry - We look to Sell at 27.69 (stop at 30.03) The primary trend remains bearish. Trading within a Corrective Channel formation. The trend of higher highs is located at 26.80. Previous support at 27.40 now becomes resistance. We look for a temporary move higher. Preferred trade is to sell into rallies. Our profit targets will be 22.02 and...
Novavax - 30d expiry - We look to Sell a break of 15.49 (stop at 17.01) Daily signals are bearish. There is no clear indication that the downward move is coming to an end. Prices are extending lower from the bearish flag/pennant formation. Posted a bearish Flag formation. A break of 15.50 is needed to confirm the outlook. The bias is to break to the...
Accumulation or distribution? Wychoff wants to know! Phase C, Spring Stage? M.Cap is below CASH, Best in Class vaccine with over 43+ International Approvals. It’s just amazing what Nova’s teams have be able to accomplish(for its size) around the globe!
Some signs of strength for NVAX. The trend has more work in order to change but it is going really well.